Localized Delivery of a Small Molecule Hedgehog Agonist via Poly(ε‐caprolactone) Scaffolds Enhances Tendon‐to‐Bone Integration
Journal of Orthopaedic Research · 2026-04 · 44 (4)
DOI: 10.1002/jor.70183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 30.03.2026. Verfasst von Jonathan Marcelin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hedgehog Proteins, Tissue Scaffolds, Tendons, Bone and Bones. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Tendon and ligament injuries often require surgery, with successful recovery, whether direct repair of a torn tendon to bone or reconstruction of ligaments, requiring effective tendon‐to‐bone integration. Unfortunately, re‐tear rates can be high, demonstrating the need for improved treatment strategies. The Hedgehog (Hh) pathway is critical to fibrocartilage formation at tendon and ligament insertion sites during development, and recent studies indicate that it promotes tendon‐to‐bone integration post‐surgery. However, systemic delivery of Hh signaling agonists can result in off‐target effects. In this study, we developed a scaffold system for local delivery of a Hh signaling agonist (SAG) to promote tendon‐to‐bone integration. We fabricated aligned electrospun scaffolds loaded with four concentrations of SAG and quantified the fiber alignment and diameter, which were not different between the different concentrations. We then measured the in vitro release profile and found a dose‐dependent release of SAG from the scaffolds, as measured by expression of the downstream Hh target gene, Gli1, in bone marrow stromal cell cultures that received conditioned media. Finally, we combined the scaffolds with tendon grafts and inserted them into bone tunnels created in the proximal tibiae of mice. SAG released from the scaffolds did not affect cell infiltration in the graft or scaffold, but increased expression of Gli1 by cells in the bone tunnels while also increasing mineralized fibrocartilage formation in a dose‐dependent manner. These findings indicate that scaffold‐mediated local delivery of SAG can effectively enhance tendon‐to‐bone integration, offering a promising strategy for treating tendon and ligament injuries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Nathaniel A Dyment
Förderung
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Marcelin, J., Madi, R., Kamalitdinov, T. B., Jiang, X., Kim, D. H., Mauck, R. L., Kuntz, A. F., & Dyment, N. A. (2026). Localized Delivery of a Small Molecule Hedgehog Agonist via Poly(ε‐caprolactone) Scaffolds Enhances Tendon‐to‐Bone Integration. Journal of Orthopaedic Research, 44(4). https://doi.org/10.1002/jor.70183
Vancouver
Marcelin J, Madi R, Kamalitdinov TB, Jiang X, Kim DH, Mauck RL, et al. Localized Delivery of a Small Molecule Hedgehog Agonist via Poly(ε‐caprolactone) Scaffolds Enhances Tendon‐to‐Bone Integration. Journal of Orthopaedic Research. 2026;44(4). doi:10.1002/jor.70183
BibTeX
@article{Marcelin2026,
author = {Marcelin, Jonathan and Madi, Rashad and Kamalitdinov, Timur B and Jiang, Xi and Kim, Dong Hwa and Mauck, Robert L and Kuntz, Andrew F and Dyment, Nathaniel A},
title = {Localized Delivery of a Small Molecule Hedgehog Agonist via Poly(ε‐caprolactone) Scaffolds Enhances Tendon‐to‐Bone Integration},
journal = {Journal of Orthopaedic Research},
year = {2026},
volume = {44},
number = {4},
doi = {10.1002/jor.70183}
}
EUVIMED